Needham Maintains Buy on Veracyte, Raises Price Target to $35
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Mike Matson maintains a 'Buy' rating on Veracyte (NASDAQ:VCYT) and raises the price target from $34 to $35.
August 09, 2023 | 10:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a 'Buy' rating on Veracyte and raises the price target from $34 to $35. This could potentially lead to an increase in the stock's price.
The raised price target by Needham indicates a positive outlook for Veracyte. This could potentially lead to an increase in the stock's price as it suggests that the analyst believes the stock is undervalued at current levels. Therefore, this news is likely to have a positive impact on Veracyte's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100